Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.
Standard
Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. / Eyding, Dirk; Lelgemann, Monika; Grouven, Ulrich; Härter, Martin; Kromp, Mandy; Kaiser, Thomas; Kerekes, Michaela F; Gerken, Martin; Wieseler, Beate.
In: BMJ-BRIT MED J, Vol. 341, 2010, p. 4737.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.
AU - Eyding, Dirk
AU - Lelgemann, Monika
AU - Grouven, Ulrich
AU - Härter, Martin
AU - Kromp, Mandy
AU - Kaiser, Thomas
AU - Kerekes, Michaela F
AU - Gerken, Martin
AU - Wieseler, Beate
PY - 2010
Y1 - 2010
N2 - To assess the benefits and harms of reboxetine versus placebo or selective serotonin reuptake inhibitors (SSRIs) in the acute treatment of depression, and to measure the impact of potential publication bias in trials of reboxetine.
AB - To assess the benefits and harms of reboxetine versus placebo or selective serotonin reuptake inhibitors (SSRIs) in the acute treatment of depression, and to measure the impact of potential publication bias in trials of reboxetine.
M3 - SCORING: Zeitschriftenaufsatz
VL - 341
SP - 4737
JO - BMJ-BRIT MED J
JF - BMJ-BRIT MED J
SN - 0959-535X
ER -